International Flavors & Fragrances Health & Biosciences — Net Sales increased by 1.0% to $595.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.2%, from $540.00M to $595.00M. Over 4 years (FY 2021 to FY 2025), Health & Biosciences — Net Sales shows relatively stable performance with a -0.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth indicates successful market penetration and demand for the segment's product portfolio.
The total revenue generated from the sale of goods and services within the Health & Biosciences segment, net of returns,...
Standard top-line revenue metric reported by all public companies by segment.
iff_segment_health_biosciences_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $639.00M | $618.00M | $646.00M | $661.00M | $665.00M | $512.00M | $501.00M | $513.00M | $522.00M | $518.00M | $518.00M | $529.00M | $556.00M | $568.00M | $550.00M | $540.00M | $577.00M | $577.00M | $589.00M | $595.00M |
| QoQ Change | — | -3.3% | +4.5% | +2.3% | +0.6% | -23.0% | -2.1% | +2.4% | +1.8% | -0.8% | +0.0% | +2.1% | +5.1% | +2.2% | -3.2% | -1.8% | +6.9% | +0.0% | +2.1% | +1.0% |
| YoY Change | — | — | — | — | +4.1% | -17.2% | -22.4% | -22.4% | -21.5% | +1.2% | +3.4% | +3.1% | +6.5% | +9.7% | +6.2% | +2.1% | +3.8% | +1.6% | +7.1% | +10.2% |